跳至主要内容
临床试验/NCT00594269
NCT00594269已完成4 期

Discontinuation of Antipsychotics and Antidepressants Among Patients With Dementia and BPSD Living in Nursing Homes - a 24 Weeks Double Blind RCT.

Sykehuset Innlandet HF8 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
149
试验地点
8
主要终点
Changes in UPDRS subscale

研究概览

简要总结

The aim of this study is to discontinue antipsychotics and antidepressants, and to study its effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).

详细描述

Patients with dementia have cognitive deficits, but also hallucinations, delusions, agitation, aggression and apathy. These symptoms are called Behavioural- and Psychological Symptoms in Dementia (BPSD), and are difficult to treat. Antipsychotic and antidepressant medication is used as treatment, despite its lack of clinical evidence.

We will discontinue risperidone in one group of 30 patients and compere them to 30 controls and we will discontinue antidepressants in a group of 76 patients and compere them to 76 controls. Patients should have dementia of Alzheimer- or vascular origin. They should live in Nursing Homes and have no other psychiatric disease for which they receive psychotropic drug. They will be registered with 7 different questionnaires at baseline and after 3, 6, 12 and 24 weeks. The study period is 24 weeks. The questionnaires are filled in by the patients and the nurses at the nursing homes.

This is a double blind RCT study with placebo-controlled group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • Vascular- or Alzheimer Dementia
  • Nursing Homes resident for 3 months or more
  • Given antipsychotics or antidepressants for 3 months or more
  • Clinical Dementia rating 1, 2 or 3

排除标准

  • Dementia of other origin
  • Psychiatric disease
  • Life expectancy less than 3 months
  • Acute infection last 10 days
  • Unstable Diabetes Mellitus
  • Terminal disease

研究组 & 干预措施

A

Placebo Comparator

Discontinuation of antipsychotic or antidepressants

干预措施: Risperidone (Drug)

A

Placebo Comparator

Discontinuation of antipsychotic or antidepressants

干预措施: Escitalopram (Drug)

A

Placebo Comparator

Discontinuation of antipsychotic or antidepressants

干预措施: Citalopram (Drug)

A

Placebo Comparator

Discontinuation of antipsychotic or antidepressants

干预措施: Sertraline (Drug)

A

Placebo Comparator

Discontinuation of antipsychotic or antidepressants

干预措施: Paroxetine (Drug)

结局指标

主要结局

Changes in UPDRS subscale

时间窗: 24 weeks

Changes in Cornell's Depression Scale

时间窗: 24 weeks

Changes in Neuropsychiatric Inventory

时间窗: 24 weeks

次要结局

  • Changes in Severe Impairment Battery(24 weeks)
  • Changes in Lawton's PADL(24 weeks)
  • Oxazepam given p.n.(24 weeks)
  • Number of falls(24 weeks)
  • Changes in Body Weight(24 weeks)
  • Quality of Life - Alzheimer disease(24 weeks)
  • Clinical Dementia Rating(24 weeks)

研究者

申办方类型
Other

研究点 (8)

Loading locations...

相似试验